300804 广康生化
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.5972.6593.17717.22120.906
总资产报酬率 ROA (%)1.6701.8172.17411.33513.797
投入资产回报率 ROIC (%)1.9362.0292.36112.83915.947

边际利润分析
销售毛利率 (%)24.51220.75624.03029.28131.606
营业利润率 (%)7.5754.0756.28616.10518.332
息税前利润/营业总收入 (%)9.2856.2047.75215.75318.766
净利润/营业总收入 (%)6.3334.7336.07514.57415.660

收益指标分析
经营活动净收益/利润总额(%)88.42964.68795.130103.847102.330
价值变动净收益/利润总额(%)12.40228.00313.2710.000-0.017
营业外收支净额/利润总额(%)-7.24814.690-1.657-2.663-2.849

偿债能力分析
流动比率 (X)1.9782.0392.0401.2821.374
速动比率 (X)1.5591.7531.7210.8900.851
资产负债率 (%)37.79633.32929.78935.10133.039
带息债务/全部投入资本 (%)26.83120.75324.14924.91120.435
股东权益/带息债务 (%)267.592373.771310.606292.624375.006
股东权益/负债合计 (%)164.454199.875235.690184.890202.674
利息保障倍数 (X)4.1804.3484.943239.80019.925

营运能力分析
应收账款周转天数 (天)83.55481.727100.65161.72848.056
存货周转天数 (天)126.54095.970118.40381.800105.986